GreenTec Holdings (TSXV:GTEC) is pleased to announce that wholly owned subsidiary Zenalytic Laboratories (“Zen Labs”) has completed its on-site inspection with Health Canada to become a Licensed Dealer, under the Narcotic Control Regulations of Canada.

On June 26th, 2018, Health Canada’s Regional Regulatory Compliance & Enforcement Team was on-site for a scheduled inspection of Zen Labs’ facility located in Kelowna BC. The purpose of the inspection was to confirm that Zen Lab’s security plans met Health Canada’s Directive On Physical Security Requirements, and that all the necessary Standard Operating Procedures, Document Control, Record Keeping and any other key factors pertaining to Zen Labs receiving its final license have been met.


On May 23rd, 2018 and June 25th, 2018, GTEC had previously announced that this inspection was to satisfy the Directive on Physical Security Requirements only, and that “Zen Labs expects a follow up inspection on implementation of its instruments, SOP’s, record keeping and analytical processes before being granted its final License”. However, during the on-site inspection, Health Canada has confirmed, that a follow up inspection will not be required and this would be the only inspection conducted prior to issuing a license.

Given that Zen Labs consists of an experienced and qualified team, complemented by the regulatory support and gap analysis from Cannabis Compliance Inc, the company anticipates that a final license will be granted by Health Canada within a timely manner. If the license is approved, Zen Labs would be authorized to possess, transport, analyze and conduct research & development with cannabis. Furthermore, upon final licensing approvals, Zen Labs intends to apply for amendments to the license to further conduct other activities relating to cannabis.

“As we strive to establish ourselves as a leading vertically integrated company, this puts GTEC and its group of companies, one step closer towards reaching this objective.” said Norton Singhavon, Chairman & CEO of GTEC Holdings. “Obtaining a Licensed Dealer will allow for GTEC to control the entire process of cultivation, extraction and quality assurance, internally with full accountability through the eco-system we have worked diligently to create”

Zen Labs is also pleased to announce the hiring of Lasoi Ketere. Ms. Ketere has joined Zen Labs as Qualified Person In-Charge (“QPIC”). Ms. Ketere has past experience with analytical chemistry and organic hydrocarbon extractions. Prior to joining Zen Labs, Ms. Ketere was QPIC and RPIC at Medisca Pharmaceutique Inc, a global leader in providing pharmaceutical compounding chemicals and products. Where Ms. Ketere was responsible for ensuring Health Canada Regulations were met, and oversaw import/export applications to the Office of Controlled Substances. Ms. Ketere was also in-charge of the company’s controlled substances department adhering to Good Manufacturing Practices (“GMP”) guidelines. Her experience with highly regulated controlled substances, and Health Canada’s regulatory processes will benefit Zen Labs and the GTEC group of companies tremendously.

Fore information about the Narcotic Control Regulations, please visit Health Canada’s website on Narcotic Control Regulations under the Controlled Drug and Substances Act.
(http://laws-lois.justice.gc.ca/eng/regulations/C.R.C.,_c._1041/FullText.html)

About Zen Labs

Zen Labs is a full service chemical and microbiological diagnostics laboratory for soil, water, and cannabis. Zen Labs is in the process of obtaining a Section 56 Class Exemption Dealer’s License under the Narcotic Control Regulations. Zen Labs will analyze cannabinoid profiles, moisture content, heavy metals, microbials, aflatoxins, pesticides and other contaminants as per the regulations set out by Health Canada’s ACMPR, for Licensed Producers, Production for Own Medical Purposes, Production by a Designated Person, and individuals who are authorized for personal medical consumption. Zen Labs also intends to be able to conduct full analytical testing on terpene profiling and residual solvents for authorized clients.

About GreenTec

GreenTec was founded in 2017 to capitalize on opportunities in the nascent and rapidly growing legal cannabis industry. GreenTec is a public corporation listed on the TSX Venture Exchange and based in Kelowna, British Columbia. GreenTec is focused on growing premium quality craft cannabis in purpose-built indoor facilities. GreenTec currently holds a 100% interest in GreenTec Bio-Pharmaceuticals Corp., Grey Bruce Farms Inc., Zenalytic Laboratories Ltd., Falcon Ridge Naturals Ltd., Alberta Craft Cannabis Inc. (formerly Grenex Pharms Inc.), and Tumbleweed Farms Corp.

To view more about the company or to request our most recent corporate presentation, please visit our website at www.gtec.co

On behalf of the board,

Norton Singhavon
Chairman & CEO

Michael Blady
Co-Founder & Vice President

For additional information please contact:

GTEC Holdings Ltd.
1-800-351-6358
contact@gtec.co

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities of the Company have not been and will not be registered under the United States Securities Act of 1933, as amended and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirement. This press release shall not constitute an offer to sell or the solicitation of an offer to buy nor shall there be any sale of the securities in any jurisdiction in which such offer, solicitation or sale would be unlawful.

CAUTIONARY STATEMENT REGARDING FORWARD-LOOKING INFORMATION: This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but are not limited to, statements regarding the timing of receiving the license to become a Licensed Dealer under the Narcotic Control Regulations of Canada, that no further inspections are required by Health Canada, whether any planned amendments to the license, if and when granted, will be successful, and the Company’s ability to become a leading vertically integrated cannabis company, GreenTec’s cultivation capacity prior to legalization of recreational cannabis and the ability of GreenTec to become a leading craft cannabis company in Canada. Forward-looking statements are necessarily based upon a number of estimates and assumptions that, while considered reasonable, are subject to known and unknown risks, uncertainties, and other factors which may cause the actual results and future events to differ materially from those expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic, competitive, political and social uncertainties; delay or failure to receive board, shareholder or regulatory approvals, where applicable and the state of the capital markets. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Click here to connect with GreenTec Holdings (TSXV:GTEC) for an Investor Presentation.

Source: www.gtec.co

Trulieve to donate $20,000 in scholarship funding and $15,000 to support leadership development

Trulieve Cannabis Corp . (CSE: TRUL) (OTC: TCNNF), a leading and top-performing cannabis company in the United States today announced a new partnership with the Thurgood Marshall College Fund (TMCF), the nation’s largest organization exclusively representing the Black College Community. Trulieve will donate $20,000 to help fund several college scholarships awarded to students who are attending one of the organization’s member-schools as part of Trulieve’s diversity, equity, and inclusion initiatives. The $15,000 in talent funding is earmarked to support TMCF’s internship program, reaching a diverse talent pool of students and alumni from their 47 member-schools to provide immersive experiences at Trulieve.

Keep reading... Show less

The new dispensary expands patient access to Florida’s largest inventory of medical cannabis products

Trulieve Cannabis Corp. (CSE: TRUL) (OTCQX: TCNNF) (“Trulieve” or “the Company”), a leading and top-performing cannabis company based in the United States announced today the opening of a brand-new Florida dispensary, the Company’s 80th nationwide. The new location marks the Company’s first in Tamarac and third in Broward County expanding patient access to Florida’s largest and broadest assortment of high-quality medical cannabis products.

Keep reading... Show less

Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19.

With its recent $23 million dollar financing, the Company plans to aggressively expand from 14 clinical sites to up to 50 clinical sites to meet the next enrollment goals for the Study in Q2-2020. The Study is a randomized, double-blinded, placebo-controlled trial and the safety and efficacy data analyzed at each interim analysis timepoint of 210, 400, 600 and 800 completed patients are only made available to the Independent Data and Safety Monitoring Board (“DSMB”) for review and recommendations on continuation, stopping or changes to the conduct of the Study. In the event of any serious safety concerns, the DSMB would be notified to determine any risks and provide its recommendations. To date, in this initial 210 interim point there have been no serious safety concerns that required the DSMB to be notified.

Keep reading... Show less

HempFusion Wellness Inc. (TSX:CBD.U) (OTCQX:CBDHF) (FWB:8OO) (“HempFusion” or the “Company”), a leading health and wellness CBD company utilizing the power of whole-food hemp nutrition, is pleased to announce that its common shares have been approved for DTC full-service eligibility in the United States by the Depository Trust Company (“DTC”) and can now be both traded and serviced through DTC’s electronic book-entry system.

DTC is a subsidiary of the Depository Trust & Clearing Corp. (“DTCC”) that provides clearing and settlement services for the financial markets and settles the majority of securities transactions in the United States. This electronic method of clearing securities speeds up the receipt of stock and cash and thus accelerates the settlement process for investors and brokers, enabling the stock to be traded over a much wider selection of brokerage firms.

Keep reading... Show less

CFN Enterprises Inc. (OTCQB: CNFN) (CFN Media) partners with FMW Media Works LLC to produce a regular series on the global cannabis markets to air on major financial news networks across the US. Initial segment features leading cannabis analyst and US Multi-State Operator (MSO)

CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the leading media network dedicated to the global legal cannabis, CBD and psychedelics industries, today announced that its inaugural news segment on the cannabis markets, “Cannabis Market Outlook for 2021,” will air on Bloomberg, Newsmax and Fox Business.

Keep reading... Show less